These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 33119798)

  • 1. B7-H3 confers resistance to Vγ9Vδ2 T cell-mediated cytotoxicity in human colon cancer cells via the STAT3/ULBP2 axis.
    Lu H; Ma Y; Wang M; Shen J; Wu H; Li J; Gao N; Gu Y; Zhang X; Zhang G; Shi T; Chen W
    Cancer Immunol Immunother; 2021 May; 70(5):1213-1226. PubMed ID: 33119798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B7-H3 inhibits the IFN-γ-dependent cytotoxicity of Vγ9Vδ2 T cells against colon cancer cells.
    Lu H; Shi T; Wang M; Li X; Gu Y; Zhang X; Zhang G; Chen W
    Oncoimmunology; 2020; 9(1):1748991. PubMed ID: 32363121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of B7-H3 augments anti-apoptosis of colorectal cancer cells by Jak2-STAT3.
    Zhang T; Jiang B; Zou ST; Liu F; Hua D
    World J Gastroenterol; 2015 Feb; 21(6):1804-13. PubMed ID: 25684945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B7-H3 promotes multiple myeloma cell survival and proliferation by ROS-dependent activation of Src/STAT3 and c-Cbl-mediated degradation of SOCS3.
    Lin L; Cao L; Liu Y; Wang K; Zhang X; Qin X; Zhao D; Hao J; Chang Y; Huang X; Liu B; Zhang J; Lu J; Ge Q
    Leukemia; 2019 Jun; 33(6):1475-1486. PubMed ID: 30573782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD20-Specific Immunoligands Engaging NKG2D Enhance γδ T Cell-Mediated Lysis of Lymphoma Cells.
    Peipp M; Wesch D; Oberg HH; Lutz S; Muskulus A; van de Winkel JGJ; Parren PWHI; Burger R; Humpe A; Kabelitz D; Gramatzki M; Kellner C
    Scand J Immunol; 2017 Oct; 86(4):196-206. PubMed ID: 28708284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B7-H3 silencing increases paclitaxel sensitivity by abrogating Jak2/Stat3 phosphorylation.
    Liu H; Tekle C; Chen YW; Kristian A; Zhao Y; Zhou M; Liu Z; Ding Y; Wang B; Mælandsmo GM; Nesland JM; Fodstad O; Tan M
    Mol Cancer Ther; 2011 Jun; 10(6):960-71. PubMed ID: 21518725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of IL-6-JAK/Stat3 signaling in castration-resistant prostate cancer cells enhances the NK cell-mediated cytotoxicity via alteration of PD-L1/NKG2D ligand levels.
    Xu L; Chen X; Shen M; Yang DR; Fang L; Weng G; Tsai Y; Keng PC; Chen Y; Lee SO
    Mol Oncol; 2018 Mar; 12(3):269-286. PubMed ID: 28865178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B7-H3-redirected chimeric antigen receptor T cells target glioblastoma and neurospheres.
    Nehama D; Di Ianni N; Musio S; Du H; Patané M; Pollo B; Finocchiaro G; Park JJH; Dunn DE; Edwards DS; Damrauer JS; Hudson H; Floyd SR; Ferrone S; Savoldo B; Pellegatta S; Dotti G
    EBioMedicine; 2019 Sep; 47():33-43. PubMed ID: 31466914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B7-H1 and B7-H3 are independent predictors of poor prognosis in patients with non-small cell lung cancer.
    Mao Y; Li W; Chen K; Xie Y; Liu Q; Yao M; Duan W; Zhou X; Liang R; Tao M
    Oncotarget; 2015 Feb; 6(5):3452-61. PubMed ID: 25609202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B7-H3 promotes aerobic glycolysis and chemoresistance in colorectal cancer cells by regulating HK2.
    Shi T; Ma Y; Cao L; Zhan S; Xu Y; Fu F; Liu C; Zhang G; Wang Z; Wang R; Lu H; Lu B; Chen W; Zhang X
    Cell Death Dis; 2019 Apr; 10(4):308. PubMed ID: 30952834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting B7-H3 via chimeric antigen receptor T cells and bispecific killer cell engagers augments antitumor response of cytotoxic lymphocytes.
    Liu J; Yang S; Cao B; Zhou G; Zhang F; Wang Y; Wang R; Zhu L; Meng Y; Hu C; Liang H; Lin X; Zhu K; Chen G; Luo KQ; Di L; Zhao Q
    J Hematol Oncol; 2021 Jan; 14(1):21. PubMed ID: 33514401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B7-H3 regulates KIF15-activated ERK1/2 pathway and contributes to radioresistance in colorectal cancer.
    Ma Y; Zhan S; Lu H; Wang R; Xu Y; Zhang G; Cao L; Shi T; Zhang X; Chen W
    Cell Death Dis; 2020 Oct; 11(10):824. PubMed ID: 33011740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preclinical Evaluation of B7-H3-specific Chimeric Antigen Receptor T Cells for the Treatment of Acute Myeloid Leukemia.
    Lichtman EI; Du H; Shou P; Song F; Suzuki K; Ahn S; Li G; Ferrone S; Su L; Savoldo B; Dotti G
    Clin Cancer Res; 2021 Jun; 27(11):3141-3153. PubMed ID: 33531429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Negative roles of B7-H3 and B7-H4 in the microenvironment of cervical cancer.
    Han S; Wang Y; Shi X; Zong L; Liu L; Zhang J; Qian Q; Jin J; Ma Y; Cui B; Yang X; Kong B; Zhang Y
    Exp Cell Res; 2018 Oct; 371(1):222-230. PubMed ID: 30099052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA miR-29a Inhibits Colon Cancer Progression by Downregulating B7-H3 Expression: Potential Molecular Targets for Colon Cancer Therapy.
    Wang J; Chen X; Xie C; Sun M; Hu C; Zhang Z; Luan L; Zhou J; Zhou J; Zhu X; Ouyang J; Dong X; Li D; Zhang J; Zhao X
    Mol Biotechnol; 2021 Sep; 63(9):849-861. PubMed ID: 34100183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations of the Immunologic Co-Stimulator B7 and TNFR Families Correlate with Hepatocellular Carcinoma Prognosis and Metastasis by Inactivating STAT3.
    Li YM; Liu ZY; Li ZC; Wang JC; Yu JM; Yang HJ; Chen ZN; Tang J
    Int J Mol Sci; 2019 Jan; 20(1):. PubMed ID: 30609841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Locoregionally administered B7-H3-targeted CAR T cells for treatment of atypical teratoid/rhabdoid tumors.
    Theruvath J; Sotillo E; Mount CW; Graef CM; Delaidelli A; Heitzeneder S; Labanieh L; Dhingra S; Leruste A; Majzner RG; Xu P; Mueller S; Yecies DW; Finetti MA; Williamson D; Johann PD; Kool M; Pfister S; Hasselblatt M; Frühwald MC; Delattre O; Surdez D; Bourdeaut F; Puget S; Zaidi S; Mitra SS; Cheshier S; Sorensen PH; Monje M; Mackall CL
    Nat Med; 2020 May; 26(5):712-719. PubMed ID: 32341579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocellular carcinomas promote tumor-associated macrophage M2-polarization via increased B7-H3 expression.
    Kang FB; Wang L; Li D; Zhang YG; Sun DX
    Oncol Rep; 2015 Jan; 33(1):274-82. PubMed ID: 25370943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ULBP2 is a biomarker related to prognosis and immunity in colon cancer.
    Yang X; Su X; Wang Z; Yu Y; Wu Z; Zhang D
    Mol Cell Biochem; 2023 Oct; 478(10):2207-2219. PubMed ID: 36633827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The bispecific immunoligand ULBP2-aCEA redirects natural killer cells to tumor cells and reveals potent anti-tumor activity against colon carcinoma.
    Rothe A; Jachimowicz RD; Borchmann S; Madlener M; Keßler J; Reiners KS; Sauer M; Hansen HP; Ullrich RT; Chatterjee S; Borchmann P; Yazaki P; Koslowsky TC; Engert A; Heukamp LC; Hallek M; von Strandmann EP
    Int J Cancer; 2014 Jun; 134(12):2829-40. PubMed ID: 24242212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.